FAQs on Developing EMA Policy 0070 Submissions
This blog answers audience questions posed during our RAPS webinar, How to Plan for a…
Certara2025 年 9 月 15 日
The Top 10 Things You Need to Know About ADNCA Datasets
Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…
Certara2025 年 9 月 11 日
Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise
Learn how Certara's project management team helped a large biotech streamline the development and updates…
Certara2025 年 9 月 5 日
The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar
Watch Certara’s RAPS-sponsored on-demand webinar to learn how automation and expert strategies simplify patient narrative…
Certara2025 年 8 月 18 日
Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management
Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…
Certara2025 年 8 月 18 日
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma
Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…
Certara2025 年 8 月 13 日
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial
Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…
Certara2025 年 8 月 13 日
